CAITLIN REMAKLUS: Open Payments
NPI 1346943768 · RICHARDSON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,674 in 70 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $363 · 2025 $1,674
Food & beverage: $1,638Education: $36
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 13 | $271 |
| PFIZER INC. | 7 | $221 |
| JAZZ PHARMACEUTICALS INC. | 8 | $170 |
| Genentech USA, Inc. | 4 | $116 |
| Eisai Inc. | 4 | $102 |
| TG Therapeutics, Inc. | 3 | $84 |
| ACADIA Pharmaceuticals Inc | 3 | $82 |
| SK Life Science, Inc. | 3 | $67 |
| SpringWorks Therapeutics, Inc. | 2 | $56 |
| Axsome Therapeutics, Inc. | 2 | $55 |
Products named: Fintepla, NURTEC ODT, EPIDIOLEX, Ocrevus Zunovo, Leqembi, BRIUMVI, DAYBUE, ZEPOSIA.
Industry payments across TX — which companies pay providers there.
